Related Experiment Videos
Immunoglobulin abnormalities in patients with myotonic dystrophy
Acta Neurologica Scandinavica
|August 1, 1986
Summary
Patients with myotonic dystrophy (MyD) exhibit reduced immunoglobulin G (IgG) levels, which correlate with disease duration. This abnormality stems from altered IgG distribution, not broader immune dysfunction.
Area of Science:
- Immunology
- Neurology
- Genetics
Background:
- Myotonic dystrophy (MyD) is a multisystemic genetic disorder.
- Immunoglobulin (Ig) abnormalities have been anecdotally reported in MyD patients.
- The precise nature of Ig abnormalities in MyD remains unclear.
Purpose of the Study:
- To investigate immunoglobulin G (IgG) abnormalities in patients with myotonic dystrophy (MyD).
- To correlate serum IgG levels with immunological functions, clinical, and laboratory findings in MyD.
- To examine IgG turnover and distribution in MyD patients.
Main Methods:
- Serum IgG concentrations were measured in 65 MyD patients.
- Immunological functions, including lymphocyte subpopulations and proliferation, were assessed.
- IgG turnover was studied using 125I-labelled IgG to evaluate intravascular and extravascular pools and capillary permeability.
Main Results:
- A significant and selective reduction in serum IgG concentration was observed in MyD patients.
- Serum IgG levels showed a negative correlation with the duration of illness.
- Peripheral blood lymphocyte subpopulations, in vitro lymphocyte proliferation, and in vitro IgG production were normal.
- Bone marrow plasma cell populations were also normal.
- IgG turnover studies indicated an increased extravascular IgG pool and enhanced capillary permeability, leading to IgG leakage from the intravascular space.
Conclusions:
- The observed Ig abnormalities in MyD are characterized by reduced serum IgG levels.
- The reduction in serum IgG is likely due to abnormal distribution, specifically increased extravascular IgG, rather than a generalized immune deficiency.
- These findings challenge previous hypotheses suggesting broader immunological derangements in MyD.